21世纪非霍奇金淋巴瘤亚型患病率、发病率与生存趋势:瑞典淋巴瘤登记研究
该研究基于瑞典全国淋巴瘤登记系统,纳入2000–2016年确诊的非霍奇金淋巴瘤(NHL)患者,系统分析各亚型患病数、发病率、相对生存和死亡率的时序趋势。结果显示发病率上升和生存改善共同推动2016年NHL总体5年患病率较2004年增加47%,所有亚型患病率均上升,以弥漫大B细胞淋巴瘤(侵袭性亚型中,66%)和边缘区淋巴瘤(惰性亚型中,135%)最为突出。作者指出患病率大幅增加提示需开发并评估替代随访方案以高效利用资源并保障幸存者照护。
要点
- 2016年NHL总体5年患病率较2004年增加47%。
- 所有亚型患病率均上升,弥漫大B细胞淋巴瘤增66%,边缘区淋巴瘤增135%。
- 发病率上升与生存改善共同驱动患病率增加。
核心结论
- NHL总体5年患病率在2016年较2004年增加47%,所有亚型患病率均上升。
- 侵袭性亚型中以弥漫大B细胞淋巴瘤患病率增幅最显著(66%),惰性亚型中以边缘区淋巴瘤最显著(135%)。
- 患病率大幅增加提示需开发并评估替代随访方案以高效利用资源并保障淋巴瘤幸存者照护。
研究设计与样本
- 基于瑞典全国淋巴瘤登记系统的登记研究,纳入2000–2016年确诊的NHL患者。
- 估计NHL总体及主要临床和形态学亚型的发病率、死亡率、相对生存和患病率。
- 采用泊松回归检验时序趋势。
主要发现
- 2016年NHL总体5年患病率较2004年增加47%。
- 研究期间所有 investigated 亚型患病率均上升。
- 侵袭性亚型中弥漫大B细胞淋巴瘤患病率增幅为66%。
- 惰性亚型中边缘区淋巴瘤患病率增幅为135%。
临床怎么用
- 临床应关注NHL患病率持续上升带来的随访负担。
- 需开发并评估替代随访方案以高效利用资源并保障淋巴瘤幸存者照护。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Non-Hodgkin lymphoma (NHL) prognosis has improved in recent years, yet the number of patients living with the diagnosis, i.e. the prevalence, has seldom been reported. The prevalence provides a measure of the burden of disease, useful for healthcare planning and to optimise resource allocation. We provide a systematic presentation of temporal trends in absolute numbers of prevalent patients by NHL subtypes, linking them to trends in incidence, survival and mortality. Patients diagnosed 2000-2016 were identified in the national Swedish lymphoma register. Incidence and mortality rates, relative survival and prevalence were estimated for NHL overall and for major clinical and morphological subtypes. Poisson regression was used to test for temporal trends. Increasing incidence and improved survival have led to a 47% increase in the five-year prevalence of NHL overall in 2016 compared to 2004. An increasing prevalence was observed for all investigated subtypes during the study period, but most notably for diffuse large B cell lymphomas among aggressive subtypes (66%), and marginal zone lymphomas among indolent subtypes (135%). This dramatic increase in NHL prevalence underscores the need to develop and evaluate alternative follow-up schemes to use resources efficiently and still ensure optimal care of lymphoma survivors.
引用
- Ekberg S, E Smedby K, Glimelius I, et al. Trends in the prevalence, incidence and survival of non-Hodgkin lymphoma subtypes during the 21st century - a Swedish lymphoma register study. Br J Haematol. 2020. PMID: 32065396. doi:10.1111/bjh.16489
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。